Related Experiment Video
Updated: Jan 23, 2026

Antibiotic Dereplication Using the Antibiotic Resistance Platform
Published on: October 17, 2019
[The question about the topical antibiotic therapy of acute rhinosinusitis]
A A Krivopalov1, S V Ryazansev1, S A Eremin1
1Saint-Petersburg Institute of Ear, Nose, Throat and Speech, St.-Petersburg, Russia, 190013.
Abstract:
Presented the results of the clinical study of 30 patients with moderate rhinosinusitis (13 (43.3%) men, 17 (56.7%) women, age from 18 to 68 years). Among those patients, the inflammation of one paranasal sinus was observed in 7 (23.3%) cases, polysinusitis was observed in 23 (76. 7%) cases. All patients were randomized into 2 groups of 15 people. In both groups, patients received systemic antibiotic therapy, nasal irrigation therapy, and NSAIDs. In the control group, topical decongestants were used; in the experimental group the antimicrobial drug Polydexa with phenylephrine was used as a local therapy. The purpose of the study was to evaluate the clinical efficacy of Polydexa with phenylephrine in the complex treatment of moderate acute rhinosinusitis. The evaluation criteria were statistically significant comparison of clinical and laboratory parameters of both groups. Confirmed the anti-inflammatory, antimicrobial effects of the drug, made conclusions about the significant clinical efficacy, tolerability, positive effect on mucociliary clearance and safety of nasal spray Polydexa with phenylephrine.
Insights
Polydexa with phenylephrine demonstrated significant clinical efficacy in treating moderate acute rhinosinusitis. This nasal spray offers anti-inflammatory and antimicrobial benefits, improving patient outcomes and mucociliary clearance.
Area of Science:
- Otolaryngology
- Pharmacology
Background:
- Moderate acute rhinosinusitis affects a significant portion of the population.
- Current treatment often involves a combination of therapies, with a need for effective local treatments.
Purpose of the Study:
- To evaluate the clinical efficacy and safety of Polydexa with phenylephrine as a local therapy in patients with moderate acute rhinosinusitis.
- To compare the outcomes of using Polydexa with phenylephrine versus topical decongestants in conjunction with standard treatment.
Main Methods:
- A randomized clinical study involving 30 patients with moderate acute rhinosinusitis.
- Patients received systemic antibiotic therapy, nasal irrigation, and NSAIDs. The experimental group additionally received Polydexa with phenylephrine, while the control group received topical decongestants.
- Clinical and laboratory parameters were statistically compared between the two groups.
Main Results:
- Polydexa with phenylephrine demonstrated significant anti-inflammatory and antimicrobial effects.
- The experimental group showed significant clinical efficacy compared to the control group.
- The nasal spray was well-tolerated and showed a positive effect on mucociliary clearance.
Conclusions:
- Polydexa with phenylephrine is a clinically effective and safe option for the complex treatment of moderate acute rhinosinusitis.
- The drug's anti-inflammatory and antimicrobial properties contribute to improved patient outcomes and mucociliary function.
Related Concept Videos
Antibiotic Selection
Development of Antibiotic Resistance
Gene Therapy
Group Therapy
Acute Pharyngitis
Acute pharyngitis is the inflammation of the back of the throat (pharynx), commonly resulting in a sore throat. It is a frequently encountered condition that prompts individuals to seek medical advice.
Classification
Acute pharyngitis can be categorized based on its underlying cause:
Psychodynamic Therapy

